NEW YORK (GenomeWeb) – Molecular diagnostics firm ChromaCode said today it has raised $12 million in a Series B funding round.

The round was led by New Enterprise Associates with participation from existing investors, Domain Associates and Okapi Ventures.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.